Zusammenfassung: Durch die 5-HT3-Serotonin-Rezeptor-Antagonisten und durch den Neurokinin1-Rezeptor-Antagonisten Aprepitant wurde die antiemetische Behandlung wesentlich verbessert. Die Entwicklung neuer Antiemetika wurde durch ein besseres Verst\u00e4ndnis der Pathophysiologie von \u00dcbelkeit und Erbrechen erm\u00f6glicht. F\u00fcr die prophylaktische Behandlung von Chemo- oder Strahlentherapie-induzierter \u00dcbelkeit und Erbrechen gibt es aktuelle Leitlinien. Sie basieren allerdings \u00fcberwiegend auf Studien, die von der […]<\/p>\n","protected":false},"excerpt":{"rendered":"
Zusammenfassung: Durch die 5-HT3-Serotonin-Rezeptor-Antagonisten und durch den Neurokinin1-Rezeptor-Antagonisten Aprepitant wurde die antiemetische Behandlung wesentlich verbessert. Die Entwicklung neuer Antiemetika wurde durch ein besseres Verst\u00e4ndnis der Pathophysiologie von \u00dcbelkeit und Erbrechen erm\u00f6glicht. F\u00fcr die prophylaktische Behandlung von Chemo- oder Strahlentherapie-induzierter \u00dcbelkeit und Erbrechen gibt es aktuelle Leitlinien. Sie basieren allerdings \u00fcberwiegend auf Studien, die von der […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[189,268,330,2157,1071,2154,2156,704,1365,33,428,1965,701,1359,271,705,30,27,457,700,1963,1962,501,274,1744,703,699,706,702,2155,392,393,270,1073,1903,2158,1906,35,707,710,1144,2159,2160,276,708,279,1072,334,1056,280,2161,2162,709,267,798,263,266,365,1884,2153,803,802,1070,696,265,697,262,264],"class_list":["post-814","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-2-chlordesoxyadenosin","tag-5-fluorouracil","tag-5-hydroxytryptamin-rezeptor-antagonisten","tag-6-thioguanin","tag-antiemetika","tag-aprepitant","tag-bevacizumab","tag-bleomycin","tag-bortezomib","tag-busulfan","tag-capecitabin","tag-carboplatin","tag-carmustin","tag-cetuximab","tag-chemotherapie","tag-chlorambucil","tag-cisplatin","tag-cyclophosphamid","tag-cytarabin","tag-dacarbazin","tag-dactinomycin","tag-daunorubicin","tag-dexamethason","tag-docetaxel","tag-dolasetron","tag-doxorubicin","tag-emesis","tag-epirubicin","tag-erbrechen","tag-erlotinib","tag-etoposid","tag-fludarabin","tag-gemcitabin","tag-granisetron","tag-her2","tag-hexamethylmelamin","tag-human-epidermal-growth-factor-receptor-2","tag-hydroxyurea","tag-idarubicin","tag-ifosfamid","tag-irinotecan","tag-l-phenylalaninmustard","tag-mechlorethamin","tag-methotrexat","tag-mitomycin","tag-mitoxantron","tag-nausea","tag-ondansetron","tag-oxaliplatin","tag-paclitaxel","tag-palonosetron","tag-pemetrexed","tag-procarbacin","tag-radiotherapie","tag-rituximab","tag-strahlentherapie","tag-streptozocin","tag-topotecan","tag-trastuzumab","tag-tropisetron","tag-tyrosinkinase-hemmer","tag-tyrosinkinase-inhibitoren","tag-uebelkeit","tag-vinblastin","tag-vincristin","tag-vinorelbin","tag-zytostatika","tag-zytostatische-therapie"],"_links":{"self":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/814","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/comments?post=814"}],"version-history":[{"count":0,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/posts\/814\/revisions"}],"wp:attachment":[{"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/media?parent=814"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/categories?post=814"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/der-arzneimittelbrief.com\/api\/wp\/v2\/tags?post=814"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}